By rapidly recruiting alternative pathways around occluded vessels, BPC-157 addresses the consequences of thrombosis without necessarily dissolving the clot itself
The European Association for the Study of the Liver (EASL) guidelines recommend that all symptomatic patients with WD should receive a chelating agent and zinc should not be used as monotherapy[3]
Major outcome was MACE (hospitalization for acute coronary syndrome or cerebrovascular event or all-cause death), evaluated with multivariable Cox regression
Consistency is crucial for achieving optimal results
Metformin and reduced vitamin B12 levels: new advice for monitoring
Available from: Reiss AB, Gulkarov S, Lau R, Klek SP, Srivastava A, Renna HA, De Leon J